Author

April Naegeli 1

1 Eli Lilly and Company,Indianapolis,United States

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH IMPROVEMENTS IN CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MIRIKIZUMAB

Marla C. Dubinsky, Remo Panaccione, James D Lewis, Bruce E. Sands, Toshifumi Hibi, Scott D. Lee, April Naegeli, Mingyang Shan, Linden Green, Nathan Morris, Vipin Arora, Alison Potts Bleakman, Ruth Belin, Simon Travis

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED INFLAMMATORY BOWEL DISEASE RELATED QUALITY OF LIFE IN A PHASE 2 TRIAL OF MIRIKIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS

Marla C. Dubinsky, Scott D. Lee, Remo Panaccione, Maria T. Abreu, Severine Vermeire, Trevor Lissoos, Nathan Morris, Vipin Arora, Mingyang Shan, April Naegeli, Bruce E. Sands

BIOLOGIC USE IN ADULT PATIENTS NEWLY DIAGNOSED WITH CROHN'S DISEASE IN THE UNITED STATES, 2010-2013 AND 2014-2016

April Naegeli

Biologic Use in Adult Patients Newly Diagnosed with Crohn's Disease in the United States, 2010-2013 and 2014-2016

Geert R. D'Haens, April Naegeli, Malika Mahoui, Stuart Morton, Yan Dong, Theresa Hunter, Mallory Farrar, James Canavan, Diana Stefani-Hunyady

BIOLOGIC USE IN ADULT PATIENTS NEWLY DIAGNOSED WITH ULCERATIVE COLITIS IN THE UNITED STATES, 2010-2013 AND 2014-2016

April Naegeli

Biologic Use in Adult Patients Newly Diagnosed with Ulcerative Colitis in the United States, 2010-2013 and 2014-2016

Geert R. D'Haens, April Naegeli, Malika Mahoui, Stuart Morton, Yan Dong, Theresa Hunter, Mallory Farrar, James Canavan, Diana Stefani-Hunyady

CHARACTERISTICS OF ULCERATIVE COLITIS PATIENTS BY URGENCY OF DEFECATION AT ENROLLMENT IN THE CORRONA INFLAMMATORY BOWEL DISEASE REGISTRY

Douglas C. Wolf, April Naegeli, Mingyang Shan, Theresa Hunter Gibble, Angelina Sontag, Page Moore, Rachel Mackey, Margaux Crabtree, Raymond Cross

EFFECT OF 52 WEEKS OF MIRIKIZUMAB ON INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE SCORES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Laurent Peyrin-Biroulet, Bruce E. Sands, William Sandborn, Peter D.R. Higgins, Fumihito Hirai, Vipul Jairath, Ruth Belin, Yan Dong, Elisa Gomez Valderas, Debra Miller, Vipin Arora, April Naegeli, Paul Pollack, Jay Tuttle, Toshifumi Hibi

EFFECT OF MIRIKIZUMAB ON INFLAMMATORY BIOMARKERS IN A PHASE 2 STUDY OF PATIENTS WITH CROHN'S DISEASE

Geert R. D'Haens, Stefan Schreiber, Edouard Louis, Bruce E. Sands, Elisa Gomez Valderas, Debra Miller, Noah Agada, April Naegeli, Paul Pollack, Jochen Schmitz, Janneke van der Woude, Jaroslaw KierkuĊ›, William Sandborn

EFFICACY AND IMPROVED HEALTH-RELATED QUALITY OF LIFE AFTER 52-WEEKS OF MIRIKIZUMAB TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: AN UPDATE FROM A RANDOMISED, DOUBLE-BLIND, CONTROLLED, PHASE 2 STUDY

April Naegeli

Item 1 - 10 / 21
1
2 3